RANKL inhibition is an effective adjuvant for docetaxel in...

The Prostate 2008 Vol. 68; Iss. 8

RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model

K. M. Woods Ignatoski, J. F. Escara-Wilke, J.-L. Dai, A. Lui, W. Dougall, S. Daignault, Z. Yao, J. Zhang, M. L. Day, E. E. Sargent, E. T. Keller
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
68
Year:
2008
Language:
english
Pages:
10
DOI:
10.1002/pros.20744
File:
PDF, 362 KB
english, 2008
Conversion to is in progress
Conversion to is failed